EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gaussian process regression of HDR prostate biopsy dose for improved modelling of localization‐induced uncertainty

Matthew Muscat iD, Juanita Crook iD, Andrew Jirasek iD, Jeffrey Andrews iD, Nathan Becker iD

Medical Physics · 2026-11 · 53 (11)

DOI: 10.1002/mp.70712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, online erschienen am 01.11.2026. Verfasst von Matthew Muscat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computer Science, Mathematics, Physics and Statistics, Irving K. Barber Faculty of Science, University of British Columbia Okanagan, Ke…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Brachytherapy, Prostate, Radiation Dosage. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Walter C. Sumner Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biopsy‐level dose interpretation after high‐dose‐rate prostate brachytherapy is limited by localization uncertainty, and separate voxelwise Monte Carlo summaries do not explicitly account for the axial spatial correlation present along a biopsy core.

Purpose

To develop and internally evaluate a biopsy‐level Gaussian process regression framework for assigning along‐core high‐dose‐rate prostate brachytherapy dose under localization uncertainty, and to test whether explicit modelling of axial spatial correlation improves uncertainty characterization relative to voxelwise Monte Carlo summaries treated independently.

Methods

We analyzed 27 MR‐informed, transrectal‐ultrasound (TRUS)‐guided transperineal template biopsies from 15 patients treated with high‐dose‐rate prostate brachytherapy. For each biopsy voxel, Monte Carlo localization perturbations were propagated to generate dose summaries and voxel‐specific variances. Biopsy‐specific empirical semivariograms were fitted with candidate covariance kernels, and ordinary‐mean heteroscedastic Gaussian process posteriors were computed along each core. Internal evaluation included latent‐profile residual diagnostics, kernel‐sensitivity analysis, and blocked cross‐validation using contiguous held‐out axial segments scored on held‐out points only.

Results

For the selected baseline kernel, Matérn , the across‐biopsy median voxel‐averaged standard deviation was 6.91 Gy for the Monte Carlo summaries and 2.60 Gy for the latent GP posterior. The median within‐biopsy reduction was 59.1%, with a median shrinkage ratio of 2.45. Fitted length scales were heterogeneous across biopsies, with median mm, while nugget fractions were typically small. Cohort standardized residuals were near‐centered with conservative spread. In blocked cross‐validation, predictive performance on held‐out points remained favorable, with median root‐mean‐square error of 1.99 Gy, median mean absolute error of 1.58 Gy, and median negative log predictive density of 3.28. Among the tested kernels, held‐out predictive error favored Matérn .

Conclusion

Along‐core dose interpretation after localization uncertainty should use a spatially correlated model rather than separate voxelwise summaries alone. This Gaussian process framework provides a covariance‐informed posterior dose representation with held‐out internal validation and offers a practical basis for biopsy‐level probabilistic quality assurance and future dose‐response analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBrachytherapyProstateRadiation DosageHumansMaleNormal DistributionUncertaintyRadiotherapy DosageMonte Carlo MethodRegression AnalysisBiopsy

Stichwörter der Autor:innen

gaussian process regressionhdr brachytherapylocalization uncertaintyprobabilistic quality assuranceprostate biopsy dosimetry

Autor:innen und Institutionen

  • Department of Computer Science, Mathematics, Physics and Statistics, Irving K. Barber Faculty of Science, University of British Columbia Okanagan, Kelowna, British Columbia, Canada.
  • BC Cancer, Kelowna, British Columbia, Canada.
  • Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Surgery, University of British Columbia, Kelowna, British Columbia, Canada.

ORCID-Profile: Matthew Muscat, Juanita Crook, Andrew Jirasek, Jeffrey Andrews, Nathan Becker

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Walter C. Sumner Fellowship

Zitieren

APA

Muscat, M., Crook, J., Jirasek, A., Andrews, J., & Becker, N. (2026). Gaussian process regression of HDR prostate biopsy dose for improved modelling of localization‐induced uncertainty. Medical Physics, 53(11). https://doi.org/10.1002/mp.70712

Vancouver

Muscat M, Crook J, Jirasek A, Andrews J, Becker N. Gaussian process regression of HDR prostate biopsy dose for improved modelling of localization‐induced uncertainty. Medical Physics. 2026;53(11). doi:10.1002/mp.70712

BibTeX
@article{Muscat2026,
  author = {Muscat, Matthew and Crook, Juanita and Jirasek, Andrew and Andrews, Jeffrey and Becker, Nathan},
  title = {Gaussian process regression of HDR prostate biopsy dose for improved modelling of localization‐induced uncertainty},
  journal = {Medical Physics},
  year = {2026},
  volume = {53},
  number = {11},
  doi = {10.1002/mp.70712}
}
Kostenlos starten →